Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status

Authors:
Publisher website
Google Scholar
Abstract
Tailoring medication dosing for the individual patient is complex, and many factors can influence drug exposure. We investigated the effect of age and CYP2D6 genotype on aripiprazole and dehydroaripiprazole exposure in patients using long-acting injectable (LAI) or oral aripiprazole.
Funding Information
  • South-Eastern Norway Regional Health Authority (2017085)
  • South-Eastern Norway Regional Health Authority (2016097)

This publication has 48 references indexed in Scilit: